HIGHLIGHTS
- who: Zhiliang Jia from the University of Verona, Italy have published the Article: IL12 immune therapy clinical trial review: Novel strategies for avoiding CRS-associated cytokines, in the Journal: PLoS One 2018; Safety and tolerability of HIV-1 multiantigen pDNA vaccine given with IL-12 plasmid DNA IL-12 DNA/ 13(9): e0202753 via electroporation, boosted with a recombinant vesicular stomatitis virus HIV Gag vaccine in i.m. (26). healthy volunteers in a randomized, controlled clinical trial of /2018/
- what: No greater than grade 1 local toxicity was observed from any patient in this trial . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.